|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Operating expenses | |
| Research and development | |
| General and administrative | |
| Total operating loss | |
| Non-operating income | |
| Interest income | |
| Realized gain on sale of marketable securities, net | |
| Gain (loss) on change in fair value of derivative instruments | |
| Total non-operating income | |
| Loss before income tax | |
| Income tax provision | |
| Net loss | |
| Net loss per share, basic | |
| Net loss per share, diluted | |
| Weighted average shares outstanding used in calculating net loss per share, basic | |
| Weighted average shares outstanding used in calculating net loss per share, diluted |
Loading...
